STAAR Surgical Co. (STAA)
22.11
-0.28
(-1.25%)
USD |
NASDAQ |
Aug 28, 16:00
22.10
-0.01
(-0.05%)
After-Hours: 20:00
STAAR Surgical Free Cash Flow : -6.749M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.749M |
| March 31, 2026 | -54.99M |
| December 31, 2025 | -40.05M |
| September 30, 2025 | -39.54M |
| June 30, 2025 | -43.74M |
| March 31, 2025 | -31.35M |
| December 31, 2024 | -7.669M |
| September 30, 2024 | 26.30M |
| June 30, 2024 | 13.55M |
| March 31, 2024 | 20.88M |
| December 31, 2023 | -3.594M |
| September 30, 2023 | -33.53M |
| June 30, 2023 | -0.534M |
| March 31, 2023 | 16.76M |
| December 31, 2022 | 17.61M |
| September 30, 2022 | 22.47M |
| June 30, 2022 | 23.68M |
| March 31, 2022 | 18.56M |
| December 31, 2021 | 30.32M |
| September 30, 2021 | 43.91M |
| June 30, 2021 | 32.41M |
| March 31, 2021 | 27.51M |
| December 31, 2020 | 12.55M |
| September 30, 2020 | 1.956M |
| June 30, 2020 | 3.642M |
| Date | Value |
|---|---|
| March 31, 2020 | 6.763M |
| December 31, 2019 | 15.62M |
| September 30, 2019 | 10.62M |
| June 30, 2019 | 9.062M |
| March 31, 2019 | 7.455M |
| December 31, 2018 | 10.52M |
| September 30, 2018 | 9.736M |
| June 30, 2018 | 4.831M |
| March 31, 2018 | 4.31M |
| December 31, 2017 | 1.807M |
| September 30, 2017 | 0.469M |
| June 30, 2017 | -1.667M |
| March 31, 2017 | 0.891M |
| December 31, 2016 | -2.156M |
| September 30, 2016 | -4.46M |
| June 30, 2016 | -4.577M |
| March 31, 2016 | -5.655M |
| December 31, 2015 | -4.207M |
| September 30, 2015 | -6.66M |
| June 30, 2015 | -7.778M |
| March 31, 2015 | -10.53M |
| December 31, 2014 | -12.00M |
| September 30, 2014 | -7.482M |
| June 30, 2014 | -4.765M |
| March 31, 2014 | -2.451M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Intuitive Surgical, Inc. | 3.223B |
| Enovis Corp. | 63.66M |
| Stryker Corp. | 4.702B |
| Zimmer Biomet Holdings, Inc. | 1.079B |
| Edwards Lifesciences Corp. | 1.434B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 19.69M |
| Cash from Investing (Quarterly) | -1.366M |
| Cash from Financing (Quarterly) | -1.502M |
| Free Cash Flow Per Share (Quarterly) | 0.3727 |
| Free Cash Flow to Equity (Quarterly) | 20.55M |
| Free Cash Flow to Firm (Quarterly) | 19.20M |
| Free Cash Flow Yield | -0.60% |